Trichloroethylene

HCID 6575CAS 123919-09-5

Grundinformationen

Standard-SMILES
ClC=C(Cl)Cl
InChIKey
XSTXAVWGXDQKEL-UHFFFAOYSA-N
Summenformel
C2HCl3
Durchschnittliche Molmasse
131,38 g/mol
Monoisotopische Masse
129,91438307

Überblick

Trichloroethylene (TCE) is a nonflammable, colorless liquid with a somewhat sweet odor and a sweet, burning taste. It is used mainly as a solvent to remove grease from metal parts, but it is also an ingredient in adhesives, paint removers, typewriter correction fluids, and spot removers. Trichloroethylene is not thought to occur naturally in the environment. However, it has been found in underground water sources and many surface waters as a result of the manufacture, use, and disposal of the chemical.

Namen und Bezeichner

Bevorzugter Name
Trichloroethylene
IUPAC
1,1,2-trichloroethene
Englischer Name
Trichloroethylene
Summenformel
C2HCl3
Molmasse
131.39

Namen und Synonyme

TRICHLOROETHYLENETrichloroethene79-01-61,1,2-TrichloroetheneEthinyl trichloride1,1,2-TrichloroethyleneEthene, trichloro-Ethylene trichlorideGermalgeneWestrosolDensinfluatNarkosoid
Weitere Namen anzeigen
TrethyleneAcetylene trichlorideAnamenthNarcogenTrileneTrichlorethyleneChlorilenChlorylen

Datenbank-Bezeichner

CAS
123919-09-5、79-01-6
PubChem CID
6575
DTXSID
DTXSID0021383
ChEMBL
CHEMBL279816
ChEBI
CHEBI:16602
UNII
290YE8AR51
EC Number
201-167-4
Nikkaji
J4.408C

Eigenschaften

Berechnete Struktureigenschaften

XLogP
2,6
Polarare Oberfläche (TPSA)
0 Ų
H-Brücken-Donoren
0
H-Brücken-Akzeptoren
0
Frei drehbare Bindungen
0
Schwere Atome
5

Experimentelle und physikochemische Eigenschaften

Chemical Classes · 3 Einträge

Hazardous Air Pollutants (HAPs)

Urban Hazardous Air Pollutants (HAPs) - EPA specified greatest potential health threat in urban areas

Carcinogens

DrugsPharmaceuticals -> Listed in ZINC15
SolventsSolvents -> Chlorinated Aliphatics
SpringerMaterials PropertiesSchoenflies notation
Pesticides · 2 Einträge

Pesticide -> EPA IRIS

Volatile Organic Compound (VOC) (Pesticide/Volatile Organic Compound (VOC))

LogP · 3 Einträge

log Kow = 2.61

2.42

2.42

Sicherheit und Regulatorisches

GHS-Klassifizierung

GHS Classification · 6 Einträge

Danger

H315: Causes skin irritation [Warning Skin corrosion/irritation]

P203, P261, P264, P264+P265, P271, P273, P280, P302+P352, P304+P340, P305+P351+P338, P318, P319, P321, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)

Danger

H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]

P203, P261, P264, P264+P265, P271, P272, P273, P280, P302+P352, P304+P340, P305+P351+P338, P318, P319, P321, P332+P317, P333+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)

Gefahrenhinweise

Regulatory Information · 6 Einträge

Chemical: Ethene, 1,1,2-trichloro-

Hazard Traits - Carcinogenicity; Cardiovascular Toxicity; Developmental Toxicity; Hepatotoxicity and Digestive System Toxicity; Nephrotoxicity and Other Toxicity to the Urinary System; Neurotoxicity; Ocular Toxicity; Reproductive Toxicity; Respiratory Toxicity

Ethene, 1,1,2-trichloro- is listed on the EPA's Chemical Data Reporting (CDR) system. Manufacturers and importers of Ethene, 1,1,2-trichloro- are required to report information about their production and use of this chemical to the EPA under the Toxic Substances Control Act (TSCA). (40 eCFR Part 711)

R - indicates a substance that is the subject of a TSCA section 6 risk management rule.

Status: Active Update: 23-11-2021 https://echa.europa.eu/registration-dossier/-/registered-dossier/14485

Substance: Trichloroethylene

Other Safety InformationPEC / SN / Other assessments - Trichloroethylene: Health and Environment
DOT LabelPoison
Fire Hazards · 3 Einträge

Special Hazards of Combustion Products: Toxic and irritating gases are produced in fire situations. (USCG, 1999)

· Some of these materials may burn, but none ignite readily.

Combustible under specific conditions. Gives off irritating or toxic fumes (or gases) in a fire.

Fire Potential · 3 Einträge

Nonflammable, but high concentrations of trichloroethylene vapor in high-temperature air can be made to burn mildly if plied with a strong flame.

This chemical is a combustibe liquid.

At normal handling temperatures, trichloroethylene behaves as a non-flammable, non-burnable substance.

Health Hazards · 2 Einträge

INHALATION: symptoms range from irritation of the nose and throat to nausea, an attitude of irresponsibility, blurred vision, and finally disturbance of central nervous system resulting in cardiac failure. Chronic exposure may cause organic injury. INGESTION: symptoms similar to inhalation. SKIN: defatting action can cause dermatitis. EYES: slightly irritating sensation and lachrymation. (USCG, 1999)

· Toxic by ingestion.

Sicherheit und Schutzausrüstung

Fire Fighting · 2 Einträge

Excerpt from ERG Guide 160 [Halogenated Solvents]:

In case of fire in the surroundings, use appropriate extinguishing media. In case of fire: keep drums, etc., cool by spraying with water.

First Aid Measures · 4 Einträge

Fresh air, rest. Artificial respiration may be needed. Refer immediately for medical attention.

Remove contaminated clothes. Rinse and then wash skin with water and soap.

First rinse with plenty of water for several minutes (remove contact lenses if easily possible), then refer for medical attention.

Rinse mouth. Do NOT induce vomiting. Refer immediately for medical attention.

Accidental Release Measures · 2 Einträge

· CALL 911. Then call emergency response telephone number on shipping paper. If shipping paper not available or no answer, refer to appropriate telephone number listed on the inside back cover.

· ELIMINATE all ignition sources (no smoking, flares, sparks or flames) from immediate area.

First Aid · 3 Einträge

EYES: First check the victim for contact lenses and remove if present. Flush victim's eyes with water or normal saline solution for 20 to 30 minutes while simultaneously calling a hospital or poison control center. Do not put any ointments, oils, or medication in the victim's eyes without specific instructions from a physician. IMMEDIATELY transport the victim after flushing eyes to a hospital even if no symptoms (such as redness or irritation) develop.

General First Aid:

(General first aid procedures)

Safe StorageSeparated from metals, strong bases, food and feedstuffs, combustible substances and ignition sources. See Chemical Dangers. Dry. Keep in the dark. Keep in a well-ventilated room. Cool.
Firefighting Hazards · 1 Eintrag

Vapors are heavier than air and will collect in low areas. Vapors may travel long distances to ignition sources and flashback. Vapors in confined areas may explode when exposed to fire. Containers may explode in fire. Storage containers and parts of containers may rocket great distances, in many directions.

Toxikologische Informationen

Toxicological InformationCDC-ATSDR Toxicological Profile
Body Burden · 5 Einträge

Therapeutic or normal blood level 0.1-9 mg%

PERSONAL AIR: The exhaled breath of 73% of 26 smokers and 81% of 43 nonsmokers contained trichloroethylene at unreported concentrations(1). Breath of 12.5% of 50 individuals living in the Los Angeles area contained trichloroethylene(2). 51.2% of personal air samples collected from these 50 individuals contained trichloroethylene(2). Increased personal air exposures were reported following solvent use, household cleaning, furniture stripping, visiting a dry cleaning shop, photo developing and using paint remover of up to 220 ug/cu m from a baseline of <2 ug/cu m(3). Personal air samples from Los Angeles and Contra Costa residents contained trichloroethylene at concentrations of 7.8 ug/cu m (n = 110, Los Angeles residents, February 1984), 6.4 ug/cu m (n = 50, Los Angeles residents, May 1984) and 3.8 ug/cu m (n = 67, Contra Costa residents, June 1984)(4).

PERSONAL AIR: Personal air samples taken on 113 inner city school kids in Minneapolis, MN contained trichloroethylene in 90.3 and 72.7% at concentrations of 0.1-0.8 ug/cu m from samples taken in both the winter and spring of 2000(1). Personal air samples taken in the Boston Exposure Assessment Microenvironments study had a geometric mean of 0.17 ug/cu m in 55 nonsmoking participants, working in nonmanufacturing jobs, living in and around the greater Boston area, samples taken the summer of 2003 and winter of 2004 and 2005(2). Badge samplers worn for one week by 113 adults in 1990 and 1991 found trichloroethylene at an arithmetic mean of 2.7 and geometric mean of 1.2 ug/cu m(3). Personal air concentrations of trichloroethylene for 46 students from Philip Randolph Academy in Harlem, New York City were 2.62 and 0.51 ug/cu m in the winter and summer respectively(4). Personal air samples taken on 25 people from Battle Creek, 22 people from East St Paul and 24 people from Phillips contained an average of 0.2 ug/cu m on samples taken the spring and fall of 1999(5).

Blood samples from 179 of 277 people from the general population contained trichloroethylene at a mean concentration of 458 ng/L; a mean blood concentration of 763 ng/L was reported from 63 of 113 urban workers as compared to 180 ng/L from 82 of 127 workers(1). Blood samples collected from workers exposed to trichloroethylene in 4 dry-cleaning shops (air concentrations ranged from 25-40 ppm) contained this compound (median = 3.39 umol/L after work (range 0.46-12.71), 0.38 umol/L before work (range = 0.15-3.58)(2). Urine samples from the same workers contained the trichloroethylene metabolite, trichloroethanol (median 54.89 umol/mol creatine, range 5.30-177.67 after work; median = 9.70 umol/mol creatine, range 0.38-35.65 before work)(2). Kidney (n = 9), lung (n = 13), and muscle (n = 16) tissues collected from humans in Turku, Finland in 1987 contained trichloroethylene at 0.7, 0.02, and 0.2 ug/kg, respectively(3). Trichloroethylene was detected in 20% of composite adipose tissue samples collected in FY82 (n 46 composite samples)(4). Breathing air samples from 30 residents of Tokyo, Japan had a mean concentration of 2.0 ug/cu m trichloroethylene with a calculated daily intake due to breathing ambient air of 40 ug/person (men 24.9 ug/person; women 51.5 ug/person)(5). Breath samples of Los Angeles and Contra Costa residents contained trichloroethylene at concentrations of 1.6 (n = 110, Los Angeles residents, February 1984), 1.0 (n = 50, Los Angeles residents, May 1984) and 0.6 ug/L (n = 67, Contra Costa residents, June 1984)(6).

For more Body Burden (Complete) data for Trichloroethylene (6 total), please visit the HSDB record page.

TreatmentThere is no known antidote for trichloroethylene. Exposure is usually handled with symptomatic treatment. (L15)
Cancer Sites · 2 Einträge

Hematologic

[in animals: liver & kidney cancer]

Interactions · 5 Einträge

Exposure to trichloroethene (TCE), a ubiquitous environmental contaminant, is known to induce autoimmunity both in humans and animal models. ... Previous studies ... in MRL+/+ mice suggest that oxidative stress may contribute to TCE-induced autoimmune response. The current study was undertaken to further assess the role of oxidative stress in TCE-induced autoimmunity by supplementing with an antioxidant N-acetylcysteine (NAC). Groups of female MRL+/+ mice were given TCE, NAC or TCE+NAC for 6 weeks (TCE, 10 mmol/kg, i.p., every 4th day; NAC, 250 mg/kg/day through drinking water). TCE exposure led to significant increases in serum levels of anti-nuclear, anti-dsDNA and anti-Sm antibodies. TCE exposure also led to significant induction of anti-malondiadelhyde (MDA)- and anti-hydroxynonenal (HNE)-protein adduct antibodies which were associated with increased ANA in the sera along with increased MDA-/HNE-protein adducts in the livers and kidneys, and increases in protein oxidation (carbonylation) in the sera, livers and kidneys, suggesting an overall increase in oxidative stress. Moreover, TCE exposure also resulted in increased release of IL-17 from splenocytes and increases in IL-17 mRNA expression. Remarkably, NAC supplementation attenuated not only the TCE-induced oxidative stress, IL-17 release and mRNA expression, but also the markers of autoimmunity, as evident from decreased levels of ANA, anti-dsDNA and anti-Sm antibodies in the sera. These results provide further support to a role of oxidative stress in TCE-induced autoimmune response. Attenuation of TCE-induced autoimmunity in mice by NAC provides an approach for preventive and/or therapeutic strategies.

Toxicological interactions with drugs have the potential to modulate the toxicity of trichloroethylene (TCE). Our objective is to identify metabolic interactions between TCE and 14 widely used drugs in human suspended hepatocytes and characterize the strongest using microsomal assays. Changes in concentrations of TCE and its metabolites were measured by headspace GC-MS. Results with hepatocytes show that amoxicillin, cimetidine, ibuprofen, mefenamic acid and ranitidine caused no significant interactions. Naproxen and salicylic acid showed to increase both TCE metabolites levels, whereas acetaminophen, carbamazepine and erythromycin rather decreased them. Finally, diclofenac, gliclazide, sulphasalazine and valproic acid had an impact on the levels of only one metabolite. Among the 14 tested drugs, 5 presented the most potent interactions and were selected for confirmation with microsomes, namely naproxen, salicylic acid, acetaminophen, carbamazepine and valproic acid. Characterization in human microsomes confirmed interaction with naproxen by competitively inhibiting trichloroethanol (TCOH) glucuronidation (Ki=2.329 mM). Inhibition of TCOH formation was also confirmed for carbamazepine (partial non-competitive with Ki=70 uM). Interactions with human microsomes were not observed with salicylic acid and acetaminophen, similar to prior results in rat material. For valproic acid, interactions with microsomes were observed in rat but not in human. Inhibition patterns were shown to be similar in human and rat hepatocytes, but some differences in mechanisms were noted in microsomal material between species. ...

Trichloroethylene (TCE), a nephrotoxicant is known to cause severe damage to the kidney. In this study, the nephroprotective potential of hesperidin was evaluated against TCE-induced nephrotoxicity in Wistar rats. Oral administration of TCE (1000 mg/kg b.wt) for 15 days enhanced renal lipid peroxidation and reduced antioxidant enzymes armory viz., reduced renal glutathione, glutathione peroxidase, glutathione reductase, glutathione-S-transferase, catalase and superoxide dismutase. It also enhanced the levels of blood urea nitrogen, creatinine and kidney injury molecule (KIM-1). Caspase-3 and bax expression were found to be elevated, while that of bcl-2 reduced suggesting that TCE induces apoptosis. However, pretreatment with hesperidin at a dose of 100 and 200 mg/kg b.wt for 15 days significantly decreased lipid peroxidation, increased the levels of antioxidant enzymes and reduced blood urea, creatinine and KIM-1 levels. Hesperidin also modulated the apoptotic pathways by altering the expressions of caspase-3, bax and bcl-2 to normal. Our results suggest that hesperidin can be used as a nephroprotective agent against TCE-induced nephrotoxicity.

It /has been/ demonstrated that some drugs modulate in vitro metabolism of trichloroethylene (TCE) in humans and rats. The objective was to assess in vivo interactions between TCE and three drugs: naproxen (NA), valproic acid (VA), and salicylic acid (SA). Animals were exposed to TCE by inhalation (50 ppm for 6 h) and administered a bolus dose of drug by gavage, equivalent to 10-fold greater than the recommended daily dose. Samples of blood, urine, and collected tissues were analyzed by headspace gas chromatography coupled to an electron capture detector for TCE and metabolites (trichloroethanol [TCOH] and trichloroacetate [TCA]) levels. Coexposure to NA and TCE significantly increased (up to 50%) total and free TCOH (TCOHtotal and TCOHfree, respectively) in blood. This modulation may be explained by an inhibition of glucuronidation. VA significantly elevated TCE levels in blood (up to 50%) with a marked effect on TCOHtotal excretion in urine but not in blood. In contrast, SA produced an increase in TCOHtotal levels in blood at 30, 60, and 90 min and urine after coexposure. Data confirm in vitro observations that NA, VA, and SA affect in vivo TCE kinetics. ...

For more Interactions (Complete) data for Trichloroethylene (23 total), please visit the HSDB record page.

Target Organs · 3 Einträge

Cancer, Developmental (effects during periods when organs are developing), Hematological (Blood Forming), Hepatic (Liver), Immunological (Immune System), Neurological (Nervous System), Renal (Urinary System or Kidneys)

Developmental

Eyes, skin, respiratory system, heart, liver, kidneys, central nervous system

Regulatorische Informationen

FDA Requirements · 2 Einträge

Trichloroethylene is an indirect food additive for use as a component of adhesives.

Tolerances are established for residues of trichloroethylene resulting from its use as a solvent in the manufacture of foods as follows: [Table#394]

RCRA Requirements · 3 Einträge

U228; As stipulated in 40 CFR 261.33, when trichloroethylene, as a commercial chemical product or manufacturing chemical intermediate or an off-specification commercial chemical product or a manufacturing chemical intermediate, becomes a waste, it must be managed according to Federal and/or State hazardous waste regulations. Also defined as a hazardous waste is any residue, contaminated soil, water, or other debris resulting from the cleanup of a spill, into water or on dry land, of this waste. Generators of small quantities of this waste may qualify for partial exclusion from hazardous waste regulations (40 CFR 261.5).

D040; A solid waste containing trichloroethylene may or may not become characterized as a hazardous waste when subjected to the Toxicity Characteristic Leaching Procedure listed in 40 CFR 261.24, and if so characterized, must be managed as a hazardous waste.

F002; When trichloroethylene is a spent solvent, it is classified as a hazardous waste from a nonspecific source (F002), as stated in 40 CFR 261.31, and must be managed according to state and/or federal hazardous waste regulations.

TSCA Requirements · 2 Einträge

Trichloroethylene (TCE) is a volatile organic compound widely used in industrial and commercial processes and has some limited uses in consumer and commercial products. EPA identified significant health risks associated with TCE use in vapor degreasing and EPA's proposed determination is that these risks are unreasonable risks. To address these unreasonable risks, EPA is proposing under section 6 of the Toxic Substances Control Act (TSCA) to prohibit the manufacture (including import), processing, and distribution in commerce of TCE for use in vapor degreasing; to prohibit commercial use of TCE in vapor degreasing; to require manufacturers, processors, and distributors, except for retailers of TCE for any use, to provide downstream notification of these prohibitions throughout the supply chain; and to require limited recordkeeping.

Trichloroethylene (TCE) is a volatile organic compound widely used in industrial and commercial processes and has some limited uses in consumer and commercial products. EPA identified significant health risks associated with TCE use in aerosol degreasing and for spot cleaning in dry cleaning facilities. EPA has preliminarily determined that these risks are unreasonable risks. To address these unreasonable risks, EPA is proposing under section 6 of the Toxic Substances Control Act (TSCA) to prohibit the manufacture, processing, and distribution in commerce of TCE for use in aerosol degreasing and for use in spot cleaning in dry cleaning facilities; to prohibit commercial use of TCE for aerosol degreasing and for spot cleaning in dry cleaning facilities; to require manufacturers, processors, and distributors, except for retailers of TCE for any use, to provide downstream notification of these prohibitions throughout the supply chain; and to require limited recordkeeping.

Atmospheric Standards · 2 Einträge

This action promulgates standards of performance for equipment leaks of Volatile Organic Compounds (VOC) in the Synthetic Organic Chemical Manufacturing Industry (SOCMI). The intended effect of these standards is to require all newly constructed, modified, and reconstructed SOCMI process units to use the best demonstrated system of continuous emission reduction for equipment leaks of VOC, considering costs, non air quality health and environmental impact and energy requirements. Trichloroethylene is produced, as an intermediate or a final product, by process units covered under this subpart.

Listed as a hazardous air pollutant (HAP) generally known or suspected to cause serious health problems. The Clean Air Act, as amended in 1990, directs EPA to set standards requiring major sources to sharply reduce routine emissions of toxic pollutants. EPA is required to establish and phase in specific performance based standards for all air emission sources that emit one or more of the listed pollutants. Trichloroethylene is included on this list.

CERCLA Reportable Quantities · 1 Eintrag

Persons in charge of vessels or facilities are required to notify the National Response Center (NRC) immediately, when there is a release of this designated hazardous substance, in an amount equal to or greater than its reportable quantity of 100 lb or 45.4 kg. The toll free number of the NRC is (800) 424-8802. The rule for determining when notification is required is stated in 40 CFR 302.4 (section IV. D.3.b).

Clean Water Act Requirements · 2 Einträge

Toxic pollutant designated pursuant to section 307(a)(1) of the Federal Water Pollution Control Act and is subject to effluent limitations.

Trichloroethylene is designated as a hazardous substance under section 311(b)(2)(A) of the Federal Water Pollution Control Act and further regulated by the Clean Water Act Amendments of 1977 and 1978. These regulations apply to discharges of this substance. This designation includes any isomers and hydrates, as well as any solutions and mixtures containing this substance.

Chemie und Industrie

Pharmakologische Informationen

ATC Code · 2 Einträge

N - Nervous system

QN - Nervous system

Mechanism of Action · 2 Einträge

Trichloroethylene (TCE), dichloroacetic acid (DCA), and trichloroacetic acid (TCA) are environmental contaminants that are carcinogenic in mouse liver. 5-Methylcytosine (5-MeC) in DNA is a mechanism that controls the transcription of mRNA, including the protooncogenes, c-jun and c-myc. ... TCE decreased methylation of the c-jun and c-myc genes and increased the level of their mRNAs. Decreased methylation of the protooncogenes could be a result of a deficiency in S-adenosylmethionine (SAM), so that methionine, by increasing the level of SAM, would prevent hypomethylation of the genes. For 5 days, female B6C3F1 mice were administered, daily by oral gavage, either 1000 mg/kg bw of TCE or 500 mg/kg DCA or TCA. At 30 min after each dose of carcinogen, the mice received, by ip injection, 0, 30, 100, or 450 mg/kg methionine. Mice were euthanized at 100 min after the last dose of DCA, TCA, or TCE. Decreased methylation in the promoter regions of the c-jun & c-myc genes and increased levels of their mRNA and proteins were found in livers of mice exposed to TCE, DCA, and TCA. Methionine prevented both the decreased methylation & the increased levels of the mRNA and proteins of the two protooncogenes. The prevention by methionine of DCA- TCA-, and TCE-induced DNA hypomethylation supports the hypothesis that these carcinogenes act by depleting the availability of SAM. Hence, methionine would prevent DNA hypomethylation by maintaining the level of SAM. Furthermore, the results suggest that the dose of DCA, TCA, or TCE must be sufficient to decrease the level of SAM in order for these carcinogens to be active.

Kidney tumors (renal-cell carcinomas) from workers occupationally exposed to high levels of TCE exhibited somatic mutations of the von Hippel-Landau (VHL) tumor suppressor gene, a gene that has been associated with renal-cell carcinoma. Mutations in the VHL gene were found in 75% of renal-cell carcinomas from 44 TCE-exposed persons. DNA sequencing analysis showed that 39% of these tumors had a specific mutation, a C to T transition at nucleotide (nt) 454, resulting in a Pro to Ser amino acid change at codon 81. In four patients, the nt 454 mutation also was found in the nearby noncancerous kidney tissue. Moreover, this mutation was specific to TCE exposure, because it was not found in renal-cell carcinomas from patients not exposed to TCE, and it was related to the disease, because it was not found in germline DNA from either diseased or nondiseased individuals. It is reasonable from a biological perspective that the kidney tumors observed in humans are related to TCE exposure because (1) the site and histopathological characteristics of the tumors in humans and experimental animals are similar, (2) a portion of the molecular mechanism of this type of cancer (nephrocarcinogenicity) has been discovered, (3) the metabolites derived from TCE (the likely ultimate electrophilic intermediates of its bioactivation) are identical in humans and experimental animals, and (4) taking the key urinary metabolites (mercapturic acids) as an indicator of the bioactivation of TCE, humans seem to be more sensitive than rats in developing the primary biochemical lesion that precedes kidney cancer.

Biological Half-Life · 6 Einträge

Whole body: 53 hours; for trichloroethanol in blood: 12 hours; for trichloroacetic acid in urine: 75 hours; [TDR, p. 1181]

The biological half-lives of the urinary metabolites of humans occupationally exposed to trichloroethylene /is/ approx 41 hours.

The half-life of trichloroethylene in exhaled air & in the blood depends on the length of exposure & on the time of sampling after exposure. ... Maximum concentration /of trichloroethanol/ in blood & urine /is reached/ almost directly after exposure. ... concentration decreases with a half-life of about 10-15 hr. ... Concentration of trichloroacetic acid in both the blood & urine increases for up to 20-40 hr after /a single/ exposure. ... concentration decreases with a half-life of about 70-100 hr.

Trichloroethanol and its glucuronide are rapidly eliminated in urine, with half-lives of about 10 hr, and trichloroacetic acid is eliminated slowly, with a half-life of about 52 hr (range, 35-70 hr).

... Trichloroethylene has an estimated half- life in humans in venous blood of 21.7 hours ... .

For more Biological Half-Life (Complete) data for Trichloroethylene (8 total), please visit the HSDB record page.

Metabolism/Metabolites · 6 Einträge

... We collected urine from Hartley male and female guinea pigs 24 hours after intracutaneous injection of trichloroethylene (TRI), trichloroethanol (TCE) or trichloroacetic acid (TCA) during a guinea pig maximization test and measured the urinary metabolites by gas chromatography-mass spectrometry. After TRI treatment, the amount of TCA was significantly greater in females than males, while there was no sex difference in the total amount (TCA + TCE). TCA was only detected in urine after TCA treatment. Interestingly, not only TCE but also TCA was detected in urine of both sexes after TCE treatment, and the amount of TCA was also greater in females than males. An additional experiment showed that TCE treatment did not result in the detection of urinary TCA in cytochrome P450 (CYP)2E1-null mice TCE but did in wild-type mice, suggesting the involvement of CYP2E1 in the metabolism from TCE to TCA. The constitutive expression of CYP2E1 in the liver of guinea pigs was greater in females than males. The sex difference in urinary TCA excretion after TRI and TCE treatments may be due to variation of the constitutive expression of CYP2E1.

Toxicological interactions with drugs have the potential to modulate the toxicity of trichloroethylene (TCE). Our objective is to identify metabolic interactions between TCE and 14 widely used drugs in human suspended hepatocytes and characterize the strongest using microsomal assays. Changes in concentrations of TCE and its metabolites were measured by headspace GC-MS. Results with hepatocytes show that amoxicillin, cimetidine, ibuprofen, mefenamic acid and ranitidine caused no significant interactions. Naproxen and salicylic acid showed to increase both TCE metabolites levels, whereas acetaminophen, carbamazepine and erythromycin rather decreased them. Finally, diclofenac, gliclazide, sulphasalazine and valproic acid had an impact on the levels of only one metabolite. Among the 14 tested drugs, 5 presented the most potent interactions and were selected for confirmation with microsomes, namely naproxen, salicylic acid, acetaminophen, carbamazepine and valproic acid. Characterization in human microsomes confirmed interaction with naproxen by competitively inhibiting trichloroethanol (TCOH) glucuronidation (Ki=2.329 mM). Inhibition of TCOH formation was also confirmed for carbamazepine (partial non-competitive with Ki=70 uM). Interactions with human microsomes were not observed with salicylic acid and acetaminophen, similar to prior results in rat material. For valproic acid, interactions with microsomes were observed in rat but not in human. Inhibition patterns were shown to be similar in human and rat hepatocytes, but some differences in mechanisms were noted in microsomal material between species. ...

... In this study we have compared the renal toxicity of TCE and /its major metabolite trichloroethanol/ (TCE-OH) in rats to try and ascertain whether the glutathione pathway or formic aciduria can account for the toxicity. Male rats were given TCE (500 mg/kg/day) or TCE-OH at (100 mg/kg/day) /by oral gavage/ for 12 weeks and the extent of renal injury measured at several time points using biomarkers of nephrotoxicity and prior to termination assessing renal tubule cell proliferation. The extent of formic aciduria was also determined at several time points, while renal pathology and plasma urea and creatinine were determined at the end of the study. TCE produced a very mild increase in biomarkers of renal injury, total protein, and glucose over the first two weeks of exposure and increased Kim-1 and NAG in urine after 1 and 5 weeks exposure, while TCE-OH did not produce a consistent increase in these biomarkers in urine. However, both chemicals produced a marked and sustained increase in the excretion of formic acid in urine to a very similar extent. The activity of methionine synthase in the liver of TCE and TCE-OH treated rats was inhibited by about 50% indicative of a block in folate synthesis. Both renal pathology and renal tubule cell proliferation were reduced after TCE and TCE-OH treatment compared to controls. Our findings do not clearly identify the pathway which is responsible for the renal toxicity of TCE but do provide some support for metabolism via glutathione conjugation.

Extraplacental membranes define the gestational compartment and provide a barrier to infectious microorganisms ascending the gravid female reproductive tract. We tested the hypothesis that bioactive metabolites of trichloroethylene (TCE) decrease pathogen-stimulated innate immune response of extraplacental membranes. Extraplacental membranes were cultured for 4, 8, and 24 hr with the TCE metabolites trichloroacetate (TCA) or S-(1,2-dichlorovinyl)-l-cysteine (DCVC) in the absence or presence of lipoteichoic acid (LTA) or lipopolysaccharide (LPS) to simulate infection. In addition, membranes were cocultured with DCVC and Group B Streptococcus (GBS). DCVC (5-50 uM) significantly inhibited LTA-, LPS-, and GBS-stimulated cytokine release from tissue cultures as early as 4 hr (P </= 0.05). In contrast, TCA (up to 500 uM) did not inhibit LTA-stimulated cytokine release from tissue punches. Because cytokines are important mediators for host response to infectious microorganisms these findings suggest that TCE exposure could potentially modify susceptibility to infection during pregnancy.

For more Metabolism/Metabolites (Complete) data for Trichloroethylene (24 total), please visit the HSDB record page.

Trichloroethylene has known human metabolites that include Chloral hydrate.

MeSH Pharmacological Classification · 2 Einträge

Liquids that dissolve other substances (solutes), generally solids, without any change in chemical composition, as, water containing sugar. (Grant &amp; Hackh&apos;s Chemical Dictionary, 5th ed)

Gases or volatile liquids that vary in the rate at which they induce anesthesia; potency; the degree of circulation, respiratory, or neuromuscular depression they produce; and analgesic effects. Inhalation anesthetics have advantages over intravenous agents in that the depth of anesthesia can be changed rapidly by altering the inhaled concentration. Because of their rapid elimination, any postoperative respiratory depression is of relatively short duration. (From AMA Drug Evaluations Annual, 1994, p173)

Absorption, Distribution and Excretion · 5 Einträge

Blood and urine samples were collected in 1990 from 10 people working in four dry cleaning shops in Croatia, where trichloroethylene was used as the cleaning solvent. The concentration of trichloroethylene in the air was 25-40 ppm [134-215 mg/cu m]. The mean blood levels of trichloroethylene were 0.38 umol/L [50 ug/L] on Monday morning (range, 0.15- 3.58 umol/L) (20-70 ug/L) and 3.39 umol/L [445 ug/L] on Wednesday afternoon (range, 0.46- 12.71 umol/L (60-1670 ug/L]. ...

TCE is rapidly absorbed into the systemic circulation via the oral and inhalation routes. The majority of TCE undergoes oxidation in the liver by CYPs, with a small proportion being conjugated with glutathione (GSH) via glutathione S-transferases (GSTs). Thus, two distinct metabolic pathways exist for TCE. ... TCE may be oxidized to yield one of three initial metabolites: chloral, TCE-epoxide, and dichloroacetylchloride. These metabolites rapidly undergo oxidation and/or reduction to yield trichloroacetate (TCA) and trichloroethanol (TCOH), the major end products of the oxidative pathway. TCOH is either oxidized to TCA or glucuronidated. TCOH glucuronide is excreted via the urine and bile. That in the bile may undergo enterohepatic recirculation by hydrolysis to TCOH in the gut, with reabsorption and the possibility of conversion to TCA. TCA accumulates in the body due to strong plasma protein binding and slow excretion. In contrast, blood levels of DCA, formed by TCA dechlorination or from TCOH, are very low or nondetectable in humans. Relatively small amounts of TCE can be conjugated in the liver with GSH to form S-(1,2-dichlorovinyl)glutathione (DCVG). DCVG is then effluxed from the hepatocyte into plasma and bile for translocation to the kidney and small intestine, respectively. The plasma DCVG is intrarenally converted by gamma-glutamyltransferase and dipeptidases to the cysteine conjugate S-(1,2-dichlorovinyl)-L-cysteine (DCVC). The DCVG secreted into the bile can undergo extrarenal processing to DCVC, that is subsequently delivered to the kidney by enterohepatic recirculation. DCVC represents a branch point in the pathway. It may be detoxified through N-acetylation or bioactivated to reactive thiols via renal beta-lyase located in renal proximal tubular cells (or to a lesser extent, bioactivated to DCVC sulfoxide via flavin-containing monooxygenases).

TCE is rapidly and extensively absorbed by all routes of environmental exposure, including oral ingestion, inhalation and skin contact. Absorbed TCE is distributed throughout the body, where it can accumulate in fat and other tissues.

... The pharmacokinetics of trichloroethylene (TCE) in male Sprague-Dawley (S-D) rats were characterized (1) during and after inhalation exposure to 50 or 500 ppm TCE, (2) following administration of 8 mg/kg TCE PO, and (3) following intra-arterial injection of 8 mg/kg TCE. Blood and tissues (including liver, kidney, fat, skeletal muscle, heart, spleen, gastrointestinal tract, and brain) were collected at selected time-points from 5 min up to 24 hr post initial exposure. The fat compartment was modified to be diffusion-limited to predict the observed slow release of TCE from the fat. The addition of a deep liver compartment was necessary to accurately predict the slower hepatic clearance of TCE for all three exposure routes. Simulations of liver concentrations following gavage of male B6C3F1 mice with 300-2000 mg/kg TCE were also improved with the addition of a deep liver compartment. Liver predictions were calibrated and validated using a cross-validation technique novel to PBPK modeling. Splitting of compartments did not significantly affect predictions of TCE concentrations in the liver, fat, or venous blood. ...

For more Absorption, Distribution and Excretion (Complete) data for Trichloroethylene (23 total), please visit the HSDB record page.

Verwendung und Herstellung

Uses · 6 Einträge

The main use of trichloroethylene is in the vapor degreasing of metal parts. Trichloroethylene is used in consumer products such as typewriter correction fluids, paint removers/strippers, adhesives, spot removers, and rug-cleaning fluids.

Used extensively form 1920s through 1970s as a degreaser in metal fabrication, but use declined because of concerns about environmental pollution and cancer; TCE used in about 50% of vapor degreasing in 1970s and about 33% in 1980s. Increased EPA regulations in 1990s further limited its use. Other industries using TCE: dry cleaning, textile, electronics, leather, and rubber; Also used in adhesives, drugs, paints, and inks; [Reference #2]

Banned in the US in 1977 as a pet food additive, grain fumigant, wound disinfectant, obstetrical anesthetic, and extractant to make decaffeinated coffee; [ATSDR ToxProfile] In US industries, the process use of TCE ended in the mid-1980s; [PMID 24224613]

Metal Degreasing [Category: Clean]

Preparing and mounting animal skins (taxidermy) [Category: Hobbies]

For trichloroethylene (USEPA/OPP Pesticide Code: 081202) there are 0 labels match. /SRP: Not registered for current use in the U.S., but approved pesticide uses may change periodically and so federal, state and local authorities must be consulted for currently approved uses./

Impurities · 3 Einträge

Acidity (as hydrochloric acid), 0.0005% max; alkalinity (as sodium hydroxide), 0.001% max; residue on evaporation, 0.005% max; antioxidants, such as amine (0.001-0.01% or more) or combinations of epoxides such as epichlorohydrin & esters (0.2-2% total)

Apart from added stabilizers, commercial grades of trichloroethylene should not contain more than the following amounts of impurities: water, 100 ppm; acidity (as HCl), 5 ppm; insoluble residue, 10 ppm. Free chlorine should not be detectable.

Impurities that have been found in commercial trichloroethylene products include: carbon tetrachloride, chloroform, 1,2-dichloroethane, trans-1,2-dichloroethylene, cis-1,2-dichloroethylene, pentachloroethane, 1,1,1,2-tetrachloroethane, 1,1,2,2-tetrachloroethane, 1,1,1-trichloroethane, 1,1,2-trichloroethane, 1,1-dichloroethylene, tetrachloroethylene, bromodichloromethane, bromodichloroethylene, and benzene.

U.S. Exports · 2 Einträge

(1985) 1.06X10+10 g

Exports were 65 million pounds during 1996, but averaged 83 million pounds per year in the 1992-1996 period.

U.S. Imports · 2 Einträge

(1985) 1.98X10+10 g

Imports last year totaled approximately 10 million pounds, averaging 12 million pounds during the period.

U.S. Production · 6 Einträge

2023: 50,000,000 - <100,000,000 lb

USA production: (1981): 258,182 pounds.

Production quantities (1976): 610X10+6 pounds.

(1985) 7.72X10+10 g /Estimated/

(1991) 320 million lb

For more U.S. Production (Complete) data for Trichloroethylene (9 total), please visit the HSDB record page.

Consumption Patterns · 5 Einträge

Demand: (1982): 240 million pounds; (1983): Est 235 million pounds; 1987: Est 215 million pounds.

Vapor degreasing of fabricated metal parts, 80%; chemical intermediate, 5%; miscellaneous used, 5%; exports, 10% (1985)

Vapor degreasing of fabricated metal parts, 66%; chemical intermediates, miscellaneous domestic uses, 5%; exports, 22%.

Vapor degreasing of fabricated metal parts, 65%; chemical intermediates and miscellaneous uses, 35%.

Demand: 1996: 180 million pounds; 1997: 190 million pounds; 2001: 230 million pounds (includes exports)

Zugehörige Reaktionen

68

Verknüpfte Notizen

Wird geladen…